PTLA
Portola Pharmaceuticals, Inc.
PTLA
PTLA
Delisted
PTLA was delisted on the 1st of July, 2020.
204 hedge funds and large institutions have $2.36B invested in Portola Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 72 increasing their positions, 54 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 180 → 204 (+24)
22% less call options, than puts
Call options by funds: $20.7M | Put options by funds: $26.5M
Holders
204
Holding in Top 10
6
Calls
$20.7M
Puts
$26.5M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$39.3M | |
| 3 | +$24.6M | |
| 4 |
BlackRock
New York
|
+$22M |
| 5 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
+$16M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$14.9M | |
| 3 | -$14.4M | |
| 4 |
Renaissance Technologies
New York
|
-$12M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.33M |